Approved Legend Drugs For Neonatal Use
An LDM may administer the following legend drugs as approved by the Board for neonatal use:(1) Eye Prophylaxis for disease of the newborn is limited to Erythromycin Ophthalmic (0.5%) Ointment (Ilotycin, AK-Mycin and generics).(2) Prophylaxis for hemorrhagic disease of the newborn for oral use is limited to Mephyton.(3) Prophylaxis for hemorrhagic disease of the newborn for intramuscular injection includes:(a) AquaMephyton; and(b) Konakion.(4) Resuscitation is limited to medical oxygen.